Comparison of effects of DORIS remission and lupus low disease activity state (LLDAS) on disease outcomes in a multinational prospective study

Eric Morand, Vera Golder, Rangi Kandane-Rathnayake, Molla Huq, Hieu Nim, Worawit Louthrenoo, Shue Fen Luo, Aisha Lateef, Sargunan Sockalingam, Sandra Navarra, Laniyati Hamijoyo, Yasuhiro Katsumata, Madelynn Chan, Alberta Hoi, Mandana Nikpour

Research output: Contribution to conferenceAbstract

Original languageEnglish
Number of pages1
Publication statusPublished - 2019
EventInternational Congress on Systemic Lupus Erythematosus (LUPUS 2019) - San Francisco, United States of America
Duration: 5 Apr 20198 Apr 2019
Conference number: 13th
https://lupus.bmj.com/content/6/Suppl_1

Conference

ConferenceInternational Congress on Systemic Lupus Erythematosus (LUPUS 2019)
Abbreviated titleLUPUS 2019
CountryUnited States of America
CitySan Francisco
Period5/04/198/04/19
Internet address

Cite this

Morand, E., Golder, V., Kandane-Rathnayake, R., Huq, M., Nim, H., Louthrenoo, W., Luo, S. F., Lateef, A., Sockalingam, S., Navarra, S., Hamijoyo, L., Katsumata, Y., Chan, M., Hoi, A., & Nikpour, M. (2019). Comparison of effects of DORIS remission and lupus low disease activity state (LLDAS) on disease outcomes in a multinational prospective study. Abstract from International Congress on Systemic Lupus Erythematosus (LUPUS 2019), San Francisco, United States of America.